FDA Warning Letter — BP

Case 606274 — FEI 3014718234

The FDA took a Warning Letter action against BP on Apr 16, 2020 (Dayton, OH). The action was issued by CTP and concerns tobacco products.

Action Details

Facility
BP
Date
Apr 16, 2020
Fiscal Year
2020
Product Type
Tobacco
Center
CTP
Location
Dayton, OH (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.